Inhaled Nitric Oxide Market Set for Rapid Growth Amid Rising Respiratory Challenges

The global inhaled nitric oxide market, valued at $266.17 million in 2024, is projected to reach $474.72 million by 2033, growing at a CAGR of 6.64%. Key drivers include increasing cases of chronic respiratory diseases like COPD, ARDS, and neonatal respiratory distress syndrome. Emerging markets in Asia-Pacific, with India leading at a projected CAGR of 10.7%, are fueling demand. Technological advancements and rising healthcare investments further bolster growth. Major players like Air Liquide and Vero Biotech are optimizing delivery systems to meet surging needs.

 

Sources: Astute Analytica, Expert Market Research, Straits Research